Van de Velde Tommie, Thevissen Eric, Persson G Rutger, Johansson Carina, De Bruyn Hugo
Department of Periodontology and Oral Implantology, Faculty of Medicine and Health Sciences, Dental School, University of Ghent, Ghent B-9000, Belgium.
Clin Implant Dent Relat Res. 2009 Sep;11(3):183-93. doi: 10.1111/j.1708-8208.2008.00112.x. Epub 2008 Sep 9.
The Nobel Direct implant (Nobel Biocare AB, Göteborg, Sweden) was developed to minimize marginal bone resorption and to result in "soft tissue integration" for an optimized aesthetic outcome. However, conflicting results have been presented in the literature. The aim of this present study was to evaluate the clinical and microbiologic outcomes of Nobel Direct implants.
Ten partially edentulous subjects without evidence of active periodontitis (mean age 55 years) received 12 Nobel Direct implants. Implants were loaded with single crowns after a healing period of 3 to 6 months. Treatment outcomes were assessed at month 24. Routine clinical assessments, intraoral radiographs, and microbiologic samplings were made. Histologic analysis of one failing implant and chemical spectroscopy around three unused implants was performed. Paired Wilcoxon signed-rank test was used for the evaluation of bone loss; otherwise, descriptive analysis was performed.
Implants were functionally loaded after 3 to 6 months. At 2 years, the mean bone loss of remaining implants was 2.0 mm (SD +/- 1.1 mm; range: 0.0-3.4 mm). Three out of 12 implants with an early mean bone loss >3 mm were lost. The surviving implants showed increasing bone loss between 6 and 24 months (p = .028). Only 3 out of the 12 implants were considered successful and showed bone loss of <1.7 mm after 2 years. High rates of pathogens, including Aggregatibacter actinomycetemcomitans, Fusobacterium spp., Porphyromonas gingivalis, Pseudomonas aeruginosa, and Tanerella forsythia, were found. Chemical spectroscopy revealed, despite the normal signals from Ti, O, and C, also peaks of P, F, S, N, and Ca. A normal histologic image of osseointegration was observed in the apical part of the retrieved implant.
Radiographic evidence and 25% implant failures are indications of a low success rate. High counts and prevalence of significant pathogens were found at surviving implants. Although extensive bone loss had occurred in the coronal part, the apical portion of the implant showed some bone to implant integration.
诺贝尔直植体(瑞典哥德堡诺贝尔生物公司)的研发旨在将边缘骨吸收降至最低,并实现“软组织整合”以优化美学效果。然而,文献中呈现出相互矛盾的结果。本研究的目的是评估诺贝尔直植体的临床和微生物学结果。
10名无活动性牙周炎证据的部分牙列缺损受试者(平均年龄55岁)接受了12枚诺贝尔直植体。在3至6个月的愈合期后,直植体上安装了单冠。在第24个月时评估治疗结果。进行了常规临床评估、口腔内X光片检查和微生物采样。对一枚失败的直植体进行了组织学分析,并对三枚未使用的直植体周围进行了化学光谱分析。采用配对Wilcoxon符号秩检验评估骨丢失情况;否则,进行描述性分析。
直植体在3至6个月后进行功能加载。在2年时,剩余直植体的平均骨丢失为2.0毫米(标准差±1.1毫米;范围:0.0 - 3.4毫米)。12枚早期平均骨丢失>3毫米的直植体中有3枚丢失。存活的直植体在6至24个月期间骨丢失增加(p = 0.028)。12枚直植体中只有3枚被认为成功,2年后骨丢失<1.7毫米。发现了包括伴放线聚集杆菌、梭杆菌属、牙龈卟啉单胞菌、铜绿假单胞菌和福赛坦氏菌在内的高病原体率。化学光谱分析显示,尽管钛、氧和碳有正常信号,但也有磷、氟、硫、氮和钙的峰值。在取出的直植体根尖部分观察到骨整合的正常组织学图像。
影像学证据和25%的直植体失败表明成功率较低。在存活的直植体中发现了大量且普遍存在的重要病原体。尽管冠部发生了广泛的骨丢失,但直植体的根尖部分显示出一些骨与直植体的整合。